Non-cystic Fibrosis Bronchiectasis study: HSK31858
Official title A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
ClinicalTrials.gov ID: NCT07616375
What this study is testing
What is HSK31858?
This is an investigational tablet being studied to see if it helps people with non-cystic fibrosis bronchiectasis. It is designed to block a specific enzyme in the body called DPP1.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to find out if the drug HSK31858 is safe for people with non-cystic fibrosis bronchiectasis.
- Who it's for
- The study is looking for people who have non-cystic fibrosis bronchiectasis.
- What's involved
- Participants will receive the drug HSK31858 and be monitored for any side effects or safety issues.
- Time commitment
- The source text does not specify the duration or visit schedule for this study.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 1.Voluntarily sign the informed consent form; 2.Had previously participated in the HSK31858-301 study (having completed at least the randomization...
- 4.Women must be post-menopausal, surgically sterile, or using highly effective contraception methods from Day 1 to at least 30 days after the last...
- 5\. Males with female partners of childbearing potential must be using effective contraception from Day 1 to at least 90 days after the last dose.
You likely can't join if
- 1.In the HSK31858-301 study, there were cases of serious adverse events related to the investigational drug or people who were assessed by the...
- 2\. Any other unstable clinical condition, including but not limited to cardiovascular, gastrointestinal, hepatic, renal, neurological...
- 3.Pregnancy and lactation. 4.The investigators judged that there were other conditions that were not suitable for participation in the study.
The study team makes the final eligibility decision.
Where it is enrolling
- Yixingcun, Jiangxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Yixingcun, Jiangxi, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.